Latest News
-
Researchers helping those with osteoarthritis weave more exercise into their day
Posted on:
Our researchers at the Kolling Institute are leading a national clinical trial to support people with hip or knee osteoarthritis become more active. Study co-lead Dr Vicky Duong said we know that staying active is an important part of managing osteoarthritis symptoms, and yet 90 per cent of people with the condition are not meeting
Research Group/s & Area/s:
-
Combining medication and exercise could greatly reduce osteoporosis risk
Posted on:
Researchers from the Kolling Institute and Royal North Shore Hospital are inviting women aged 50-80 to join a study to assess the effectiveness of combining exercise with medication for better bone and muscle health in postmenopausal women. Endocrinologist and researcher Dr Shejil Kumar said we know that exercise has benefits for bone and muscle health,
Research Group/s & Area/s:
-
Unique online resource launched for Menière disease
Posted on:
Researchers from the Kolling Institute and the University of Sydney have joined with international collaborators from Spain, America, South Korea and Brazil to develop a website to improve the genetic diagnosis and management of Menière disease. The Menière Disease Atlas of Genes and Cells is a free, open resource which can be used by researchers
Research Group/s & Area/s:
-
International honour for Kolling researcher after 40-year service to spinal cord injury care
Posted on:
A career dedicated to improving the physiotherapy management of people with spinal cord injury has been recognised with the highest honour by the International Spinal Cord Society. Leading physiotherapist and researcher Professor Lisa Harvey was presented with the gold medal in front of the world’s best spinal cord injury clinicians and researchers in Belgium. Professor
Research Group/s & Area/s:
-
Podcast offers insight into the future of healthcare
Posted on:
A fascinating and informative podcast has been launched showcasing groundbreaking research, innovative healthcare, and inspiring stories from across Northern Sydney. Tomorrow’s Medicine Today is an initiative of the Northern Sydney Local Health District and the Kolling Institute, New South Wales’ oldest medical research institute. Co-hosted by the Kolling Institute’s Academic Director Professor James Elliott and leading
Research Group/s & Area/s:
-
Celebrating over 100 years of innovation
Posted on:
The inaugural Eva Kolling Research Day was staged within Royal North Shore Hospital, providing the perfect chance to celebrate the vision and generosity of a true pioneer. Established in 1920, the Kolling Institute is the oldest medical research institute in New South Wales. It has been at the forefront of cutting-edge research for more than
Research Group/s & Area/s:
-
Improving cancer detection in young people with neurofibromatosis type 1
Posted on:
Researchers from Royal North Shore Hospital and the Kolling Institute will lead Australia’s first study of whole-body screening for young people with neurofibromatosis type 1. Led by Dr Sue-Faye Siow from the department of clinical genetics, the study was awarded a grant through the RNSH Campus Research Grants Scheme, and an additional $30,000 in support
Research Group/s & Area/s:
-
International spotlight on talented Kolling neuroscience investigator
Posted on:
We would like to congratulate one of our emerging leaders at the Kolling Institute who has received a prestigious award at an international conference in Melbourne. In her final year of her PhD, Caitlin Fenech has been presented with a President’s Special Commendation award at the 36th World Congress of Neuropsychopharmacology, CINP-AsCNP 2025. Caitlin has
Research Group/s & Area/s:
-
Kolling Institute Newsletter May 2025
Posted on:
Check out our latest newsletter Click here:
Research Group/s & Area/s:
-
Multi-million dollar grant to improve treatment for lung cancer
Posted on:
Leading Royal North Shore Hospital clinician researcher Professor Nick Pavlakis and Professor Ben Solomon have secured a $14.7 million MRFF grant for a clinical trial which will explore the use of a liquid biopsy to inform treatment for lung cancer. The condition is the leading cause of cancer death in Australia and worldwide, claiming an
Research Group/s & Area/s:
